• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD; PTA BALLOON DILATATION CATHETER Back to Search Results
Catalog Number ATG120244
Medical Device Problem Codes Peeled/Delaminated (1454); Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/20/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.H10: d4 (expiry date: 12/2025).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon was allegedly ruptured at 10 atm.The procedure was completed using another device.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one atlas gold balloon catheter was returned for evaluation.Peel pebax and fiber disturbance and longitudinal rupture balloon were noted, and no other specific anomalies were noted during the visual evaluation.During the functional testing, the balloon was inflated with an in-house presto inflation device, and during the inflation, water was noted to be streaming from the balloon.Upon further examination, a longitudinal rupture was noted on the balloon.No other functional testing.All the anomalies observed under microscopic observations.During the sample analysis, peel pebax and fiber disturbance, longitudinal rupture balloon were observed during the visual evaluation, and it was also confirmed that the leakage on the balloon was caused by the longitudinal rupture that was observed under microscopic observation.Therefore, the investigation was confirmed for the reported balloon rupture and identified peel pebax and fiber disturbance.A definitive root cause for the reported balloon rupture and identified peel pebax and fiber disturbance could not be determined based upon the provided information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiration date: 12/2025), g3, h6 (device).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon was allegedly ruptured at 10 atm.The procedure was completed using another device.There was no reported patient injury.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the pta allegedly ruptured at 10 atm.The procedure was completed using another device.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: our firm received an fda email correspondence on 8-july-2024 from mdr data systems team, latania parker, indicating that the information (specifically the unique device identifier (udi) information in section d) of the previously submitted fda form 3500a, was incorrect and a request was made to submit supplemental report(s) with the entire udi number including the di and pi fields, all numbers, letters, parentheses, and symbols in the "unique device identifier (udi) #" fields.This supplemental report is in response to that request.H11: d2: medical device type-dqy; lit.D4: medical device expiration date- 12/13/2025.D4: udi-(b)(4).H4: device manufacture date- 12/13/2022.G4: k122984; k181323.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATLAS GOLD
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
FUTUREMATRIX INTERVENTIONAL
1605 enterprise street
athens 75751
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18300735
Report Number2020394-2023-01224
Device Sequence Number16950677
Product Code DQY
UDI-Device Identifier00801741061028
UDI-Public(01)00801741061028(11)221213(17)251213(10)93ZG0056
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K122984
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/13/2025
Device Catalogue NumberATG120244
Device Lot Number93ZG0056
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/20/2023
Supplement Date Received by Manufacturer02/15/2024
07/08/2024
Initial Report FDA Received Date12/11/2023
Supplement Report FDA Received Date02/24/2024
07/20/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/13/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-